Bullish Case: NICE's evaluation of healthcare accessibility and assistive technologies indicates a significant role in supportive services for an increasing number of people with disabilities and frailties [mdpi.com]. NICE's support of hybrid closed-loop systems for Type 1 diabetes suggests the organization's adaptability in endorsing technologically advanced medical solutions [fiercebiotech.com, medtechdive.com].


Show historical bullish cases

Bearish Case: NICE's questionable reputation in guidance development and economic evaluation could undermine the organization's credibility. There are concerns about unfair restrictions and potential undue influences from the pharmaceutical industry [BMJ, BMJ].


Show historical bearish cases

Takeaway: NICE's pursuit of technological advancement in medical solutions shows promise. However, the organization needs to address reputational issues linked to its decision-making process and potential industry influences to maintain credibility.


Show historical takeaways

Potential Outcomes:

1. Growing demand for assistive technologies leading to investment in NICE's endorsed solutions (65% probability). Reasons: Increasing population of people with disabilities and frailties [mdpi.com].

2. Loss of public trust in NICE's guidelines (30% probability). Reasons: Concerns about NICE's decision-making processes and possible influence from the pharmaceutical industry [BMJ, BMJ].

3. Adoption of hybrid closed-loop systems could result in increased strategic collaborations or acquisitions by big tech and pharmaceutical companies (5% probability), given the advancement in medical technologies supported by NICE [fiercebiotech.com, medtechdive.com].


November 14, 2023


NICE Forecast

[NICE]  NICE
Price Forecast: NEUTRAL    Price Action: MEAN REVERTING (?)



Make More Profitable Trades with NICE Forecasts + Trading Strategies







NICE Balanced News:


















Correlated Stock Forecasts

Assets that tend to move strongly with NICE



SWKS Forecast + Options Trading Strategies   [SWKS]  Skyworks Solutions (0.81)


QS Forecast + Options Trading Strategies   [QS]  QuantumScape (0.78)


SFIX Forecast + Options Trading Strategies   [SFIX]  Stitch Fix (0.78)


BYND Forecast + Options Trading Strategies   [BYND]  Beyond Meat (0.76)


DDD Forecast + Options Trading Strategies   [DDD]  3D Systems (0.76)



Uncorrelated Stock Forecasts

Assets with little price relationship to NICE



SMH Forecast + Options Trading Strategies   [SMH]  VanEck Vectors Semiconductor (-0.0)


ITOT Forecast + Options Trading Strategies   [ITOT]  BlackRock Institutional Trust Company N.A. - iShares Core S&P Total U.S. Stock Market (0.01)


CPE Forecast + Options Trading Strategies   [CPE]  Callon Petroleum (-0.01)


CX Forecast + Options Trading Strategies   [CX]  Cemex S.A.B. De C.V. (-0.01)


RCKT Forecast + Options Trading Strategies   [RCKT]  Rocket Pharmaceuticals (-0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against NICE



COP Forecast + Options Trading Strategies   [COP]  Conoco Phillips (-0.43)


FNGR Forecast + Options Trading Strategies   [FNGR]  FingerMotion (-0.48)


AMGN Forecast + Options Trading Strategies   [AMGN]  AMGEN (-0.5)


SFM Forecast + Options Trading Strategies   [SFM]  Sprouts Farmers Market (-0.53)


TWM Forecast + Options Trading Strategies   [TWM]  ProShares UltraShort Russell2000 (-0.58)